Hematologist and oncologist Amit Garg, MD, discusses the importance of using social media platforms to combat cancer ...

Phase 3 HER2CLIMB-05 trial demonstrates a 35.9% reduction in risk of disease progression or death with maintenance tucatinib combination.

The WCLC 2026 conference saw updates on new antibody-drug conjugates and treatment protocols for small cell and non-small ...

Rahul Banerjee, MD, of Fred Hutchinson Cancer Center shares highlights from the International Myeloma Society (IMS) 2026 ...

For this study, researchers developed a deep-learning based system to quantify 3-dimensional cervical neck soft tissue volumes from routine pretreatment CT simulation scans.

Significant variation seen by race, with increased likelihood of MRI in non-Hispanic Whites versus non-Hispanic Blacks ...

Habitual coffee drinking may have protective effects against various types of cancer, according to a growing body of research ...

To analyze data on outcomes and health care utilization, researchers examined a large sample of American Indian/Alaska Native patients with cancer enrolled in traditional Medicare.

A new report from the American Cancer Society provides cancer incidence, stage, survival, and mortality data for Hispanic/Latino people living in the US, as well as projected numbers of new cancer ...

(HealthDay News) — Less than 30% of women with estrogen receptor (ER)-positive early-stage breast cancer (ESBC) treated with lumpectomy remain adherent to endocrine therapy (ET) at 5 years, according ...

Appendectomy for acute appendicitis linked to lower subsequent risk for CRC compared with antibiotic management ...

In this study, researchers aimed to assess the long-term relationship between adjuvant endocrine therapy adherence and hypertension, dyslipidemia, and diabetes, while also evaluating breast cancer ...